OM1 Stock
Healthcare Technology Company
Sign up today and learn more about OM1 Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About OM1 Stock
OM1 (formerly Better Outcomes) is a digital health company focused on the measurement, comparison, and prediction of treatment outcomes. OM1 believes that a value-based healthcare system requires a much more complete view of patient outcomes than has been available until now. OM1 offers a real-world evidence platform, clinical registries and AI technologies that aim to help clients with their research, to measure and benchmark health outcomes and to personalize patient care.
OM1 was founded in 2015 by Richard Gliklich and is headquartered in Boston, Massachusetts. Notable investors include General Catalyst, Polaris Partners, and Scale Venture Partners.
Investors
7wire Ventures
Breyer Capital
Oscar Health, Circle, Shield AI, Stash Financial, Prosper Marketplace, C3 IoT, Grammarly, Etsy, Cleerly, Mark43
D1 Capital Partners
goPuff, Instacart, Anduril Industries, Lacework, Bolt, Scopely, Faire, Fivetran, Unity Technologies, Attentive
General Catalyst Partners
Snap, Jet, Stripe, Anduril Industries, Devoted Health, Lacework, Relativity Space, Oscar Health, Circle, Hopin
Kaiser Permanente
Polaris Partners
Freenome, Automattic, Club Factory, Thirty Madison, OM1, Egnyte, Quartet, Impinj, VeraCode, Xant
Scale Venture Partners
Box, Motive, Forter, DataStax, Socure, Matillion, Demandbase, WalkMe, CircleCI, BigID
Wanxiang Healthcare Investments
Funding History
| September 2015 | $1.3M |
|---|---|
| September 2015 | $4.0M |
| July 2016 | $14.9M |
| April 2018 | $21.0M |
| October 2019 | $50.0M |
| July 2021 | $85.0M |
Management
Chief Executive Officer
Rich Gliklich
Chief Financial Officer
Dennis Reilly
Press
forbes - Nov, 22 2022
OM1 Aims To Improve Healthcare Outcomes Through Big Data And AIprnewswire - Jun, 25 2022
OM1 LAUNCHES A NEW ESTIMATION MODEL FOR THE EXPANDED DISABILITY STATUS SCORE (EDSS) FOR MULTIPLE SCLEROSIS PATIENTSfiercehealthcare - Jul, 20 2021
OM1 scores $85M to build out clinical data network, AI analytics modelsbizjournals - Jul, 16 2021
AI startup OM1 bags $85M as Mass. VC deal activity reaches new highmobihealthnews - Dec, 18 2019
OM1's real-world evidence analytics banks $50M Series CEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
